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Abstract
Prion diseases are associated with the accumulation of an abnormal form of the host-coded
prion protein (PrP). It is postulated that different tertiary or quaternary structures of infec-
tious PrP provide the information necessary to code for strain properties.We show here that
different light microscopic types of abnormal PrP (PrPd) accumulation found in each of 10
sheep scrapie cases correspond ultrastructurally with abnormal endocytosis, increased
endo-lysosomes, microfolding of plasma membranes, extracellular PrPd release and inter-
cellular PrPd transfer of neurons and/or glia. The same accumulation patterns of PrPd and
associated subcellular lesions were present in each of two scrapie strains present, but they
were present in different proportions. The observations suggest that different trafﬁcking
pathways of PrPd are inﬂuenced by strain and cell type and that a single prion strain causes
several PrPd–protein interactions at the cell membrane.These results imply that strains may
contain or result in production of multiple isoforms of PrPd.
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INTRODUCTION
Scrapie of sheep is the prototype of a group of fatal neurological
diseases called transmissible spongiform encephalopathies (TSEs)
or prion diseases that include bovine spongiform encephalopathy
(BSE)ofcattleandCreutzfeldt–Jakobdiseaseofman.Thecauseof
theTSEs or prion diseases is still a matter of some debate, but most
investigators now favor the prion hypothesis (40, 41), which postu-
lates that the cause of prion diseases is an abnormal form of a
host-coded, cell surface, sialoglycoprotein called prion protein
(PrP). For many years, a major challenge to the prion hypothesis
has been to explain how an abnormal protein could code for the
existence of numerous, stable, well-characterized rodent scrapie
strains.According to this hypothesis, strain-speciﬁc information is
encodedwithintheconformationofdifferenttertiaryorquaternary
structures of an infectious isoform of PrP (41, 46).
Murine scrapie strains are characterized according to their rela-
tive incubation periods in different inbred mouse lines, different
patterns of pathology and immunochemical forms of abnormal
PrP accumulation (3, 43).A smaller number of experimental sheep
scrapie strains have been recognized by their relative incubation
times in different PrP genotypes (18). Biochemical methods are
not readily able to distinguish between natural scrapie sources,
although two experimental strains, CH1641 and BSE, have distinc-
tive molecular phenotypes (17, 26); however, both experimental
and naturally occurring scrapie sources may be distinguished by
pathologicalphenotypes(14).Thespeciﬁcparametersofthepatho-
logical phenotype that permit differentiation of strains differs for
sheep and mice: different murine strains show marked variation in
vacuolation and neuroanatomic targeting (4), but sheep scrapie
strains and sources mainly affect the same brain areas and neurons
(14). Following immunohistochemical labeling, individual sheep
strains and sources show highly diverse morphological types of
disease-associated PrP (PrPd) accumulation (14), whereas cloned
murinestrainshavefewertypesofPrPdaccumulation.Althoughthe
PrP genotype may affect the magnitude of PrPd accumulation in
sheep, the patterns and types of PrPd accumulation are not inﬂu-
enced by breed or route of inoculation (15, 35). From studies of the
proportions of different types of PrPd accumulation (the PrPd
proﬁle), we have proposed that the pathology phenotype of sheep
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different sheep scrapie agents for different cell types and by diff-
erences in the cellular processing of PrPd (15). In the present study,
we have sought to determine the nature of these putative pro-
cessing or trafﬁcking pathways of PrPd in different sheep scrapie
sources.
In previous electron microscopy immunogold studies of rodent
scrapie, we have shown that PrPd accumulates in the extracellular
space and at the plasma membrane of neurons, glial cells and
follicular dendritic cells (21, 25, 37). The degree to which the
plasma membrane and extracellular forms show a tendency to
aggregate and form ﬁbrils differs between strains and tissues, but
no differences in the nature of the changes in neurons of different
brain areas were found. In contrast, variation in neuronal pathol-
ogy both within and between neuroanatomic sites may be found
for different sheep scrapie sources (7, 8). To determine whether
there are different processing pathways for PrPd sheep scrapie
strains, we ﬁrst determined the in vivo sites of accumulation and
processing of PrPd in different naturally occurring sheep scrapie
sources and then investigated possible molecular mechanisms for
some of these changes in brain and in lymphoid tissues (the latter
is reported separately in reference 36). Our results suggest that
varying proportions of several functional conformers are present
in the brains of different sheep scrapie strains.
MATERIALS AND METHODS
The sheep included in the study and the methods of tissue ﬁxation
have been described previously (7). Brieﬂy, ten clinically affected
sheep with natural scrapie and four uninfected control animals
from New Zealand were perfused under deep surgical anaesthesia
with mixed aldehydes and post-ﬁxed in osmium tetroxide. PrP
genotypes and farms of origin are listed in Table 1. The polymor-
phisms at codons 136, 154 and 171 in the ovine PrP gene are
indicated with the appropriate amino acid single-letter code.
After perfusion, brains were removed and two serial 1 mm slices
were taken at the level of the obex. One of these slices was used for
electron microscopy. The second slice and additional brain slices
from representative brain areas were taken and processed into par-
afﬁn wax for PrPd proﬁling (14, 15). Sections were mounted, dried
overnight,dewaxedandimmersedin98%formicacid,thenwashed
and autoclaved in 0.2% citric acid for 30 minutes. Endogenous
peroxidase was inhibited with freshly prepared 3% hydrogen per-
oxide and slides were washed and blocked with 1:20 normal horse
serum for 60 minutes.All slides were incubated with the rat mono-
clonal antibody R145.The wax-embedded medulla tissue sections
werealsoimmunolabeledusingthetechniquedescribedpreviously
with the following antibodies: monoclonal anti-clathrin heavy
chain (BD biosciences, Franklin Lakes, NJ, USA), monoclonal
anti-clathrin light chain con1 (Sigma-Aldrich, Gillingham, UK),
monoclonal anti-dynamin Hudy 1 (Upstate, Dundee, Scotland),
monoclonal anti-dynamin D5 (Santa Cruz,York, UK), monoclonal
anti-amphiphysin VAM-SV030 and VAM SV031 (Bioquote Ltd.,
Heidelberg, Germany), and polyclonal anti-ubiquitin (Dako UK
Ltd.,Ely,UK).Tissueswereimmunolabeledusingtheseantibodies
both with and without formic acid and autoclave steps.
Tissuesforelectronmicroscopywereselectedunderadissecting
microscope and embedded in araldite. Light microscopic labeling
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Crown Copyright 2008of 1-mm-thick plastic-embedded tissues for PrP was performed as
described previously, but tissue sections were ﬁrst etched using
saturated sodium ethoxide immersed in 98% formic acid. Ubiq-
uitin labeling was carried out as described previously; however,
both labeling and section quality were improved with the omission
of the formic acid step.
For electron microscopy, 55 nm sections were placed on 600-
mesh gold grids and etched in sodium periodate for 60 minutes.
Endogenous peroxidase was blocked and sections de-osmicated
with 3% hydrogen peroxide in distilled water for 10 minutes fol-
lowedbyenhancementofantigenexpressionwith98%formicacid
for 10 minutes. Primary antibody (523.7, a gift from Jan Langev-
eld) at a 1:250 dilution was then applied for 15 h at 27°C and
incubated withAuroprobe™ 1 nm colloidal gold (Amersham Ltd.,
Amersham, UK). Sections were then postﬁxed with 2.5% gluteral-
dehyde in phosphate buffered saline (PBS) and labeling enhanced
with Goldenhance® (Nanoprobes Ltd.) for 10 minutes. Grids were
counterstained with uranyl acetate and lead citrate as described
previously. In order to have exact correlation for individual cells
and speciﬁc PrPd accumulation types, serial 1-mm- and 55-nm-
thick sections were labeled for PrP by light and electron micros-
copy, respectively. Ubiquitin labeling was carried out using Dako
anti-ubiquitin® antibody at a 1:50 dilution without formic acid.
Sections stained for PrPd were initially examined blind and
the number of PrPd-positive structures were recorded as negative,
sparse, few, moderate or marked. The immunogold labeling made
identiﬁcation of coated-pit associated changes more conspicuous,
reﬂecting a greater magnitude of scoring, but the trends were iden-
tical to those reported by Ersdal et al (7) on the same material.
RESULTS
Light microscopy: two distinct pathological
phenotypes indicate two strains
We assembled PrPd proﬁles on each sheep as previously described
(13, 15). Sheep could be divided into two groups according to
the presence or absence of vascular plaques and astrocyte-related
types of PrPd accumulation (Table 1).Those in which plaques were
absent tended to have higher total PrPd scores (arbitrary units),
principally manifested by higher amounts of stellate, perivascular
and perivacuolar (white matter astrocyte-associated) PrPd types. In
contrast, sheep with vascular amyloid plaques had lower amounts
of the glia-associated PrPd types. When compared with previous
data, these results show that two distinct separate strains or sources
of scrapie were present in the 10 infected subjects.
Three brainstem nuclei were selected for electron microscopic
examination:thedorsalmotornucleusofthevagalnerve(DMNV),
the spinal tract nucleus of the trigeminal nerve and olivary nuclei.
Only some of the 13 possible types of PrPd labeling present when
whole sheep scrapie brains are examined (15) were present in these
sites and are shown in Figure 1.
AB C
DE F
Figure 1. Different types of PrP
d accumulation
observed in 1-mm-thick immunolabeled
sections. In the neuropil of the dorsal motor
nucleus of the vagal nerve (DMNV), most PrP
d
accumulated in a diffuse punctate or granular
pattern (A,E). Patterns of accumulation that
clearly related to neurons included deposits
around neuronal perikarya (A) and around
neuronal processes as linear accumulations
(B). PrP
d accumulation was detected within
neuronal cytoplasm at all neuroanatomic sites
as individual (A) and perinuclear puncta or
clusters (E) of ovoidal granular deposits. Other
patterns of PrP
d accumulation included
perivascular (C) and intense coalescing
patterns often seen around glial perikarya (D).
Intense puncta of labeling, presumed to be
intracellular, was often seen adjacent to glial
cell nuclei (D). Though not distinguishable
against the diffuse or granular neuropil labeling
of the DMNV, a distinct pattern associated
with the processes of astrocytes was seen
elsewhere (F, olivary nucleus). Bar: A,6
micron; B, 6 micron; C, 20 micron; D, 6 micron;
E, 6 micron; F, 6 micron.
Immunohistochemistry for PrP
d in
0.5–1-mm-thick plastic embedded sections
using R523 antibody.
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Neuronal and dendritic plasmalemmal PrPd is
associated with abnormal endocytosis and cell
membrane transfer
In previous studies of murine scrapie, we have shown that PrPd is
found mainly on the cell membranes of neurons and dendrites.The
present study also shows that most sheep scrapie PrPd is also found
at the cell membranes of neurons and dendrites but not of axons.
Cell membrane PrPd was associated with abnormal endocytosis or
was transferred to adjacent cell membranes. In contrast to murine
scrapie, PrPd was not aggregated into ﬁbrils in the extracellular
space.
Todeterminetherelationshipbetweenlightmicroscopictypesof
PrPdandsubcellularsitesofPrPdaccumulation,individualpatterns
were identiﬁed by light microscopy in 1-mm-thick immunolabeled
sections and then located in serial sections by electron microscopy.
The light microscopy patterns of perineuronal, linear and diffuse
punctatelabeling(Figure 1A,B,E)allcorrelatedatelectronmicros-
copy with PrPd located at perikaryonal and dendritic plasma
membranes.
Inrelationtoeachofthepreviouslymentionedlightmicroscopic
types of PrPd labeling, including the punctate patterns, some PrPd
A
B
C
DE
Figure 2. PrP
d accumulation was found at the
surface of neurons and dendrites
corresponding to perineuronal, linear and
punctate patterns of labeling at light
microscopy. Some PrP
d accumulation occurred
at the plasma membrane of neurons and
dendrites in the absence of any other changes
(A). Some membrane accumulation was
associated with the formation of excess
coated pits and with the transfer to
membranes of adjacent processes (B). In
appropriate sections, the continuity between
coated pits with abnormally long necks and the
cell surface could be established (B,C,E). Some
of these pits formed fused tubular networks
beneath the cell membrane (B,C). In dendrites,
PrP
d often accumulated at two poles of the
same process, and with increasing
accumulation PrP
d, could be detected on
membranes adjacent to the cell (D) (see also
arrows at B). Complex dendrite membrane
disturbances associated with the formation of
abnormal pits incorporated the membranes of
adjacent processes; these were usually
astrocytic, but rarely, axon terminals were also
involved (E). Bar: A, 0.29 micron; B, 0.39
micron; C, 0.30 micron; D, 0.53 micron; E, 0.19
micron. A–D, PrP
d immunolabeling using R523
antibody; E, uranyl acetate/lead citrate, not
immunolabeled.
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and of dendrites with no other changes evident, neither of the
adjacent neuropil nor of the neuronal cell body or dendritic cyto-
plasm (Figure 2A).
A fraction of neuronal and dendritic plasmalemmal PrPd was
associated with morphological changes. PrPd was associated with
numerous abnormal coated pits and vesicles (Figure 2B,C). In
appropriate planes of section, vesicles were connected to the cell
surface by tubular, sometimes spiral, invaginations of the cell
membrane. PrPd labeling was found within these connecting
twisted tubules and in the associated coated structures and pits
(Figure 2B,C). Fusion of pits and vesicles resulted in complex
subplasmalemmal tubular networks (Figure 2B,C). Often, pits
and associated changes were present at two poles of a cross-
sectioned dendrite (Figure 2D); and in longitudinal sections of
dendrites, they were present as discrete focal areas distributed
discontinuously along a process. Where the entrance to the coated
pits was relatively broad, adjacent processes, usually astrocytic
but occasionally dendritic, and rarely, axon terminal membranes
(Figure 2E), extended into the mouth of the open pits. Close
proximity, and rarely, continuity between coated membranes and
PrPd-positive endosomes or lysosomes was occasionally seen.
Similar structures were not found on axons.
PrPd was also seen on the plasmalemmas of processes adjacent
to PrPd-positive dendrites and neuronal soma (Figure 2D). The
labeling of adjacent processes was indiscriminate and could
involve astrocytic processes, axonal structures, occasionally
including synaptic boutons (though we never observed involve-
ment of synaptic densities), as well as other dendrites.The surface
contours of the dendrite could be very convoluted, some showing
ﬁnger-like cytoplasmic extensions or microfolds of the plasmale-
mma (Figure 2D). The extracellular space between these folded
membranes was often increased.
Astrocyte-associated PrPd is mainly related to
plasmalemmal microfolding
When located in serial light and electron microscope prepara-
tions, perivascular, coalescing and periastrocytic types of PrPd
accumulation (Figure 1C,D,F) were associated with the plasma
membrane of astrocytes (Figure 3A). Even presumed early
accumulations of PrPd at the plasma membrane of astrocytes
were associated with complex membrane changes (Figure 3B–E).
In the presence of PrPd at the cell surface, astrocytic process
plasmalemmas became markedly irregular with many small
microfolds or projections. In areas such as the adjacent reti-
cular formation or the subependymal neuropil which con-
tained closely packed astrocytes, the nature of these ﬁnger-like
projections were more obvious (Figure 3C). In other areas, the
membranes had a linear form, which on immunolabeling
were strongly positive for PrPd. Where PrPd accumulations
associated with astrocytes were intense, astrocyte processes
were characterized by prominent glial bundles, a markedly disor-
dered neuropil and numerous microglial processes. Such
areas correlated with a coalescing pattern of PrPd accumulation
at light microscopy (Figure 3F). Rare PrPd-labeled coated
pits were seen but not in association with abnormal membrane
invaginations.
Intracellular PrPd labeling is located in lysosomes
At light microscopy, intracellular labeling was evident in neurons
(Figure 1A,E), astrocytes (Figure 1D) and microglia. Electron
microscopy showed that PrPd was located within mature and
immature lysosomes of neuronal perikarya (Figure 4A,D), occa-
sional dendrites (Figure 4C) and glial cells (Figure 4B). In favor-
able planes of sections, continuity between subplasmalemmal
endosomal or lysosomal structures and abnormal pits invaginat-
ing from the cell membrane could be identiﬁed, suggesting intra-
endosomal and intralysosomal PrPd was derived from the cell
surface PrPd.
Many neurons contained very frequent lysosomes and
endosomal–lysosomal structures, particularly in the perinuclear
Golgi zones. To determine whether lysosomes were increased in
these sheep, we performed cathepsin immunolabeling at light
microscopy and counted endosomal-lysosomal structures by elec-
tron microscopy. No increased light microscopic labeling for
cathepsin was observed, but substantially more endosomes–
lysosomes were encountered in neuronal perikarya of scrapie-
infected neurons when compared with controls in formal morpho-
metric examination (data not shown).
PrPd is associated with only some scrapie-speciﬁc
cytopathological changes
As is common with chronic end-stage neurological disease, many
different lesions are present in brains of clinically sick scrapie-
infected animals. Some of these changes are nonspeciﬁc, but a
number of changes are pathognomonic or highly indicative of
scrapie infection. As partly described previously, some scrapie-
speciﬁclesionswerecloselyassociatedwithPrPdbutotherchanges
werenot.
Several morphological features have been described in TSE-
affected brains that we consider to be pathognomonic. These are
tubulovesicular bodies (31), spiral membrane inclusions of axons
previously referred to as spiroplasma (1), highly abnormal coated
pits (7) and membrane proliferation or microfolding. Vacuolation
is not itself pathognomonic at light microscopy, but the nature
of tissue changes that surround and are present within
vacuoles appears to be a type of spongiform change unique to the
TSEs.
As in previous studies of murine scrapie, the membrane and
contents of vacuoles and tubulovesicular bodies were unlabeled
(20, 32). None of the major nonspeciﬁc degenerative features
observed, including cerebellar lamellar bodies (8), clumped synap-
tic vesicles (2), degenerate processes, dystrophic axons or autoph-
agic vacuoles, were labeled.
Spiral membrane inclusions occurred predominantly in axons
and synaptic boutons. Continuity with the cell surface was occa-
sionally evident. Unlike dendritic and neuronal membrane invagi-
nations, the coating of the axonal spiral inclusions was electron
lucent and lacked buds or branches. Some PrPd labeling was
present but to a much more limited extent than that found on the
abnormal coated pits.We hypothesize that these forms are speciﬁc,
predominantly axonal responses to dendrite-derived PrPd at the
axonal plasma-membrane.
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classical pathway
Clathrin-coated pits are involved in the endocytosis and recycling
of cell membrane proteins including normal PrPc (44).The bizarre
extensions and branching of the necks of coated pits led us to
consider the possibility that molecular abnormalities of the
endocytosis and recycling of PrPd might be involved in these
changes. We therefore investigated proteins involved in the forma-
tion of coated pits and in their excision from the plasma membrane
in several light microscopic studies. Immunohistochemistry of
clathrin, dynamin and amphiphysin showed no signiﬁcant changes
(data not shown). However, ubiquitin, which is involved in tagging
proteins for proteolysis in endosomal-lysosomes was increased.
By light microscopy, punctate ubiquitin immunolabeling was
present in neuropil of varying intensity in scrapie-affected sheep
A
C
DE
F
B
Figure 3. Patterns of accumulation of PrP
d in
association with astrocytic plasmalemma.A s
for dendrites, some PrP
d accumulation was
seen at the plasmalemma with little other
change present, but most PrP
d was associated
with a proliferative membranous change. The
simplest pattern of PrP
d labeling was present
at the plasmalemma as seen between two
adjacent astrocytic (stars) processes in (A).
In (B), PrP
d labeling is seen on the plasma
membrane of small cytoplasmic projections
(small arrows) arising from astrocytic
processes containing abundant glial ﬁlaments.
In areas where astrocytes form a dense
network of processes, the nature of the
microfolding of these projections can be more
clearly visualized (C) and is seen as
PrP
d-labeled ﬁliform cytoplasmic projections
originating from and running between glial
processes. The complex nature of the
membranes around astrocytes is shown in a
nonimmunolabeled section in (D); a indicates
astrocytic processes, n neuronal processes
and star expanded extracellular space and in a
PrP
d-labeled section in (E). The association of
PrP
d with these convoluted membranes is
shown around an astrocyte process containing
a large bundle of intermediate ﬁlaments (star).
The coalescing pattern around glial cells such
as shown in Figure 1D translates to an area
comprising extensive PrP
d-labeled membrane
microfolds and convolutions between glial
bundle-containing astrocytic processes (F).
Bar: A, 0.27 micron; B, 0.30 micron; C, 0.32
micron; D, 0.44 micron; E, 0.25 micron; F, 0.60
micron. A–C,E,F, PrP
d immunolabeling using
R523 antibody; D, uranyl acetate/lead citrate,
not immunolabeled.
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were labeled for PrPd or ubiquitin to conﬁrm sites of PrPd accumu-
lation on individual sections and then to determine levels of ubiq-
uitin at these and other sites. Conspicuous ubiquitin labeling
was associated with abnormal coated pits and subplasmalemmal
tubular networks wherever these occurred on dendrites or neuronal
cell bodies (Figure 5A). Ubiquitin was also present on the mem-
branes of other cell processes immediately adjacent to these struc-
tures (Figure 5A). In paired sections, the PrPd labeling was present
in corresponding locations. Some multivesicular bodies in den-
drites were labeled strongly for ubiquitin in both controls and
scrapie-affected sheep, though in the latter, these structures
were either not labeled for PrPd or showed only slight labeling.
Weak labeling for ubiquitin was found on endosomal–lysosomal
structures in neuronal perikarya, and rarely, in endosomal-
like structures linked with the spiral membrane inclusions
(Figure 5D).
Effect of scrapie strain on subcellular lesions and
PrPd accumulation
The same range of morphological features and immunolabeling
was seen in each of the sheep examined, but the frequency of
changes differed markedly between individuals. When sheep were
allocated to strain type, two distinct groups were evident.Thus, the
two scrapie strains present differed according to discrete differ-
ences in the proportions of lesions present (Table 1).
A
B
C D
Figure 4. Intralysosomal PrP
d accumulation
was found in several cell types. In neurons,
levels of labeling were higher on immature
lysosomes, identiﬁed by a less electron dense
content, than on mature lysosomes (arrows)
(A). Intralysosomal PrP
d was also identiﬁed in
astrocytic and microglial glial cell bodies and
processes (B) and in dendrites (C). Immature
lysosomes of neurons were generally paler,
often vacuolated and irregular in shape (D).
Bar: A, 0.88 micron; B, 0.29 micron; C, 0.33
micron; D, 0.81 micron; A–D, PrP
d
immunolabeling using R523 antibody.
AB
Figure 5. Ubiquitin labeling. Conspicuous
ubiquitin labeling was present on abnormal
coated pits at the cell membrane of dendrites
(D) and on coated pits and vesicles and on the
subplasmalemmal fused tubular complexes.
It was also present on membranes of cell
processes [in this case astrocytic processes
(A)] adjacent to such areas. Variable;
sometimes high levels of ubiquitin labeling
were found on multivesicular bodies and on
endosomal-lysosomal structures, shown here
attached to spiral inclusions (B). Bar: A, 0.37
micron; B, 0.24 micron; immunogold for
ubiquitin.
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differences in the light microscopic patterns of PrPd accumulation
when each of the 10 scrapie-affected sheep was examined.A semi-
quantitative analysis of electron microscopy lesions present in the
DMNV and in olivary nuclei was performed on coded grids.When
the magnitude of selected features are tabulated (Table 1), the 10
scrapie-affected sheep can be divided into two distinct groups
(Table 1) that correspond with the strains identiﬁed by light micro-
scopic PrPd proﬁling.The ﬁrst group showed marked formation of
PrPd-associated abnormal coated pits and associated membrane
irregularity and invaginations, increased lysosomes in neurons
(mostly PrPd positive) and had more readily detectable spiral mem-
brane inclusions. The ﬁve remaining sheep also had each of these
features but in much less abundance. However, this second group
of sheep had marked PrPd-associated proliferative and microfold-
ing membrane changes in astrocytes. These changes are morpho-
logically distinct from classical reactive astrocytosis. Thus, when
the light microscopy strain typing approaches and the electron
microscopy changes are considered together, the same groupings
are present and show that interanimal differences in PrPd-related
pathological changes differ only in magnitude and not in nature.
Nevertheless, these magnitude changes segregate according to the
strain of infection.
DISCUSSION
The present study informs on the in vivo cellular and subcellular
location of PrPd and its relationships to subcellular morphological
changes. From these observations, we can infer the sites of conver-
sion of PrPc to PrPd and the inter and intracellular trafﬁcking of
PrPd in two strains of sheep scrapie.
PrP
c to PrP
d conversion occurs at
the cell membrane
In agreement with conventional murine scrapie models that show
lysosomal, cell membrane and extracellular PrPd accumulations
(20, 21, 22), this study shows that PrPd of scrapie-affected sheep
is also associated with endosomes, lysosomes and plasma mem-
branes of neurons and glia. In previous studies of sheep scrapie
and experimental ovine BSE, we have shown that intracellular
PrPd accumulations are N-terminally truncated (23, 24), but all
other neuropil types of PrPd accumulations are full length. When
compared with these data, the present results suggest that PrPd
ﬁrst accumulates at the cell surface of neurons and dendrites from
where it is either released or internalized and then digested. In
vitro pulse-chase experiments ﬁrst suggested that the transforma-
tion of normal to abnormal PrP probably takes place at the cell
surface or at some later stage in the cell cycle (5). Our results
therefore agree with this data insofar as the ﬁrst site of the cell
cycle at which inferred full-length PrPd is visualized is at the cell
membrane.
PrP
d is internalized by an abnormal classical
endocytotic mechanism
Consistent with other glycosylphosphatidylinositol (GPI)-
anchored proteins, some studies suggest that PrPc is internalized
by one of the noncoated pit mechanisms for raft-associated pro-
teins (27, 39), but others show that PrPc is internalized from N2a
cells via coated pits (42). In N2a cells, PrPc resides within the
lipid-rich fragments of the membrane but leaves these regions
to be endocytosed within nonraft regions by a clathrin-coated
mechanism (44). As GPI-anchored proteins do not have a trans-
membrane domain, they cannot directly interact with clathrin-
associated proteins to elicit endocytotic vesicle formation; basic
residues within the N terminus of PrPc are necessary to link
between it and other membrane ligands that possess cytoplasmic
domains recognized by clathrin (44). The present study suggests
that PrPd on neuronal cell membranes is also internalized via a
coated-pit mechanism.
The bizarre tubules connecting coated pits to the cell surface
suggest that the excision of the PrPd-containing coated pits from
the plasma membrane of scrapie-infected neurons occurs inefﬁ-
ciently.WehypothesizedthatPrPdmightinterferewiththeexcision
of pits from the cell surface and attempted to identify potential
molecular defects using antibodies directed at proteins involved in
vesicle excision, but we were unable to ﬁnd any consistent changes
in the abundance of amphiphysin, dynamin or clathrin (data not
shown).We therefore propose that PrPd alters endocytosis by inter-
fering with one of the vesicle excision proteins, which then elicits
excess ubiquitin ampliﬁcation prior to endosomal degradation of
such complexes. Similar features are found in the scrapie-infected
TG3 PrP0/0 mouse, which generates PrPd from astrocytes and lack
neuronal PrPc (25). This suggests that astrocyte-derived PrPd can
be transferred to neuronal membranes and drive abnormalities of
endocytosis of abnormal PrPd. Abnormal endocytosis may there-
fore be an acquired toxic change of PrPd and may not require any
alteration in cytoplasmic expression of proteins associated with
clathrin-mediated endocytosis. In the present study, astrocytes of
scrapie-infected sheep showed PrPd internalization by normal
coated pits. We have also shown, in lymphoid tissues of the same
sheep described here, that abnormal endocytotic mechanisms are
present in macrophages internalizing PrPd. However, the macroph-
agesinternalizethePrPdviaanoncoated(probablycaveolin)medi-
ated mechanism (36). Together, these observations suggest that
membrane processing of PrPd is independent of PrPc expression
and is inﬂuenced by cell type.
Scrapie-associated alterations of the ubiquitin–proteosomal
system are reported (6, 28, 47), with one study proposing that
neurodegeneration may be caused by abnormally trafﬁcked PrPc
(34). In these scrapie-infected sheep, PrPd and ubiquitin were
presenttogetheratthecellsurface,inabnormalcoatedpits,infused
subplasmalemmal tubular networks and in a proportion of lysos-
omes but not in association with the endoplasmic reticulum or the
cytosoladjacenttoNisslorGolgibodies,suggestingthatubiquitin-
associated trafﬁcking of PrPd does not involve the proteosome.
Rather,theseresultssuggestthatPrPcconversionorPrPdaccumula-
tion signals to a cytosolic protein that can instigate the clathrin
endocytoticprocess,eitherdirectly—asaconsequenceofanabnor-
mallocationwithinthemembrane—ormoreprobablybycomplex-
ing with another ligand as previously suggested (42). This protein
complex is not recycled but directed to the endosomal system for
degradationbyubiquitinsignaling,whichappearstoincreasecellu-
lar catabolic activity as shown by increased lysosomes. Astrocyte
membrane-associated PrPd was not detectably endocytosed with
ubiquitin.Thus, mechanisms by which astrocytes and neurons deal
withcellmembrane-associatedPrPdaredifferent.
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d
Scrapie-infected cells in vitro demonstrate release of PrPd and/or
infectivity into the culture medium (9), and we have previously
shown that PrPd may also be released from the surface of scrapie-
infected mouse neurons and dendrites in vivo (21). Exosomes are
50–90-nm-diametervesiclesofendosomaloriginsthatarereleased
into the extracellular environment and can transfer PrPc from neu-
roblastoma cells to PrP null cell lines (33). We were not able to
identify exosome-like structures in routine preparations in this
or in previous rodent studies. To eliminate the possibility that
small numbers of exosomes might by chance escape detection in
two-dimensional membrane representations seen at electron
microscopy, we performed serial reconstructions of putative PrPd-
containing membrane fragments but failed to detect any exosomes
(data not shown).
PreviousstudieshaveshownthatGPI-anchoredproteins,includ-
ing PrP, may be transferred between membranes, sometimes as a
complex of molecules (33, 19). Our observations suggest that a
fraction of PrPd that reaches the cell membrane is then transferred
to other membranes of adjacent processes. This transfer is indis-
criminate and independent of cell type and also occurs in the lym-
phoid tissues of these sheep (36). As the TG3 PrP0/0 mouse also
demonstrates PrPd-associated pathology on PrP null neurons (25),
we can also infer that the transfer of PrPd between cells is indepen-
dent of PrPc expression. Because both ubiquitin and PrPd are seen
on membranes adjacent to a scrapie-infected PrPd-releasing cell,
wesurmisethatPrPdismovedbetweenmembranesasamultimeric
protein complex.
PrP
d largely accumulates on dendritic rather
than axonal membranes
Most brain PrPc appears to be located in the neuropil (10), and
previous light microscopic studies have sought to relate the diffuse
neuropil accumulation of PrPd to synapses (29). Some studies have
suggested a preferential synaptic membrane concentration of PrPc
(11, 38), but others show generalized localization on plasmalem-
mas (16, 30, 36). In these latter studies, PrPc was found to follow
standard biosynthetic pathways for GPI-anchored proteins, with
PrPc expressed in Golgi bodies and recycled through late endo-
somes after reaching the cell membrane.
At the cell surface, the GPI anchor and N-terminal domains
direct PrPc to detergent-resistant membrane (DRM) fractions (45).
However, when the DRM lipid content is experimentally altered,
PrPc is redistributed from axons to dendrites (12). In the present
study, as in previous studies of murine scrapie, we show that PrPd
accumulations in sheep are primarily related not to axons or to
synapses but to dendrites. The observed preference for PrPd accu-
mulation and release from dendrites may therefore be related to
altered trafﬁcking of the abnormal protein within the membrane or
to an altered distribution of PrPc and PrPd following changes in the
raft domains of axonal and dendritic membranes.
Scrapie strains or sources differ in the
proportion of functional PrP
d conformers
When the 10 scrapie-infected sheep investigated in the present
study were segregated according to strain or by their electron
microscopy cytopathology features (Table 1), they segregate into
the same two groups. The results therefore suggest that there
are strain-directed cytopathological effects of scrapie infection.
However, the differences in cytopathological changes observed
between the two strain groups were not qualitative but quantitative;
that is, the same PrPd-associated ultrastructural pathology was rec-
ognized for the two strains but in different proportions. This is in
agreement with previous light microscopic immunohistochemical
observations, suggesting that different strains may target some cell
populations rather than others, giving rise to, for example, a more
prominent neuron-associated rather than glia-associated morpho-
logical pattern of PrPd deposition, and that infection with different
strains may lead to a different processing of PrPd, which is trans-
lated into, for example, more abundant intracellular rather than cell
membrane aggregates (14).
Different cell types, such as neurons, glial cells and follicular
dendritic cells (36), can exhibit different cytopathological changes
when infected with the same strain of TSE agent; this is most
likely caused by biological differences between these cell
types. However, diversity of ultrastructural morphological changes
can also be found when a single strain of TSE agent infects a
particular cell type. Thus, a neuron can internalize cell membrane
PrPd via abnormal coated pits, show PrPd-associated plasma mem-
brane microfolds and can release membrane PrPd to the extracellu-
lar space or transfer it to the membranes of adjacent cells. These
different processing mechanisms result in the diversity of ultra-
structural changes described, and the fact that these vary quantita-
tively, not qualitatively, in infections by different strains can be
interpreted as follows: PrPd originating from infection with one
particular strain interacts mainly with one cell membrane protein
resulting in a main processing pathway and pathological change,
and less so with other cell membrane proteins, resulting in differ-
ent, secondary trafﬁcking pathways and less pronounced cytopa-
thology features. In this scenario, PrPd produced following infec-
tions by different strains would have distinct relative afﬁnities for
different cell membrane proteins, resulting in diverse proportions
of processing mechanisms and pathological changes. It is conceiv-
able that for this to happen, PrPd from a single strain would consist
of several tertiary or quaternary isoforms, each of which would
interact with a different cell membrane protein; different propor-
tions of those isoforms in different TSE strains would result in
relatively diverse trafﬁcking mechanisms and different proportions
of essentially the same cytopathological changes, as observed.
Either through interaction with other cell membrane proteins or on
its own, this notion ofTSE strains being composed of several PrPd
isoforms in varying proportions—rather than consisting solely of
single isoforms—appears to ﬁt better with the consistency of
pathological changes observed for particular strains. If prion
strains generated only single isoforms, the diversity of processing
mechanisms and the different resulting cytopathological changes
would be best explained as random events that would not lead to
consistent pathological phenotypes for different strains.
The scrapie-infected TG3 PrP0/0 mouse shows the same PrPd-
associated neuronal coated pit and membrane changes (25) as
found in sheep. Despite the astrocytic origin of infection in this
transgenic model, these mice did not show the same level of astro-
cytic plasma membrane proliferation of the sheep. This indicates
that the responses of both astrocytes and neurons are also directed
by speciﬁc properties of PrPd and not simply by the presence of
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nature of the PrPd isoforms that dictates the abnormal cytopathol-
ogyandinferredtrafﬁckingandnottheconverse.Ingeneral,rodent
scrapie infections release more PrPd to the extracellular space and
internalize less than sheep sources; nevertheless, the nature of the
tissue changes and sites of PrPd localization are similar for rodent
and sheep scrapie strains. We therefore suggest that every TSE
or prion infection produces a range of PrPd isoforms, each of
whichproducesdifferentcytopathologicaleffects.Therelationship
between different forms of PrPd and infectivity, and the signiﬁ-
cance of certain prion disease-speciﬁc, PrP-negative cytologi-
cal changes such as tubulovesicular structures have yet to be
established.
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